Top 11 Fastest-Growing Generics Companies #northern #pharma

Posted On Apr 21 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


The Fortune 500 s fastest-growing pharmaceutical companies #history #of #pharmaceutical #industry

Posted On Apr 20 2017 by

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …


The Fortune 500 s fastest-growing pharmaceutical companies #aristo #pharma

Posted On Mar 19 2017 by

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …


Top 11 Fastest-Growing Generics Companies #pharmaceutical #sector

Posted On Feb 13 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


The Fortune 500 s fastest-growing pharmaceutical companies #top #100 #pharmaceutical #companies

Posted On Feb 13 2017 by

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …


Top 11 Fastest-Growing Generics Companies #pharmaceutical #industry #research

Posted On Feb 2 2017 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


Top 11 Fastest-Growing Generics Companies #pharma #dictionary

Posted On Dec 20 2016 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


The Fortune 500 s fastest-growing pharmaceutical companies #pharma #pack

Posted On Dec 9 2016 by

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …


Top 11 Fastest-Growing Generics Companies #elan #pharma

Posted On Nov 23 2016 by

#generic pharma companies # Top 11 Fastest-Growing Generics Companies For generics makers, Big Pharma’s patent cliff is more like a mountain. With preparation and drive and some luck, companies that specialize in copycat drugs can climb from one newly off-patent blockbuster to another, adding millions in sales along the way. Sometimes many millions: Ranbaxy Laboratories reportedly reaped $500 million in sales from its knockoff of Pfizer’s ($PFE) cholesterol pill Lipitor during its first 6 months on the market. Plus, branded drugmakers have been diversifying to make up for plummeting sales of their no-longer-exclusive megadrugs. Sometimes, that means joining hands with …


The Fortune 500 s fastest-growing pharmaceutical companies #list #of #pharmaceutical #companies

Posted On Nov 22 2016 by

#pharmaceutical industry growth # These are the Fortune 500’s fastest-growing pharma companies The pharmaceutical industry has been rocked in recent years by a confluence of patent expirations of blockbuster drugs, increasing competition from generics and new governmental and industry efforts to control costs the world over. That s made growth prospects for many pharma companies a risky and uncertain proposition. Some have pursued growth via innovative (and expensive) new drugs, like Gilead Science s hepatitis C treatment, Sovaldi, which can cost $84,000 for a full course. Some (see: Actavis) have pursued an aggressive acquisition strategy, buying their way to growth …